SIS Medical AG – Investment by Claret Capital Partners
16 janvier 2026
Walder Wyss acted as counsel to SIS Medical AG in connection with an investment by Claret Capital Partners, whose funds provide tailored growth capital to innovative technology, life sciences and climate tech companies across Europe.
SIS Medical AG is a Swiss MedTech company focused on developing, manufacturing, and distributing innovative cardiovascular products. By joining forces with Claret Capital Partners, SIS Medical AG is significantly strengthening its ability to scale the business. Its life science expertise, entrepreneurial capabilities, and investor track record will allow to accelerate commercialization, invest further in innovation and expand its clinical portfolio.
Walder Wyss acted as counsel to SIS Medical AG. The team was led by Anaëlle Genoud (Managing Associate, Banking & Finance) and included Alexander Gutmans (Partner, Corporate / M&A), Iliana Djagova (Partner, Corporate / M&A) and Lorenzo Petrone (Associate, Corporate / M&A), as well as André Kuhn (Partner and Notary) for the notary services.